Biomarkers for Monitoring Renal Damage Due to Fabry Disease in Patients Treated with Migalastat: A Review for Nephrologists.Published in:Genes, 2022, v. 13, n. 10, p. N.PAG, doi. 10.3390/genes13101751By:Jaurretche, Sebastián;Conde, Hernan;Gonzalez Schain, Ana;Ruiz, Franco;Sgro, Maria Victoria;Venera, GracielaPublication type:Article